MAPK10(JNK3)
Sign in to save this workspaceUniProt P53779 · PDB · AlphaFold · Substrate: ATF2 · Clone: full length
Top inhibitors
| # | Drug | Inhibition | Residual | KISS | Gini |
|---|---|---|---|---|---|
| 1 | Ripretinib | 85.0% | 15.0% | 92.95 | 0.674 |
| 2 | Neratinib | 83.7% | 16.3% | 93.18 | 0.597 |
| 3 | Encorafenib | 82.1% | 17.9% | 98.50 | 0.755 |
| 4 | Fedratinib | 78.2% | 21.8% | 96.21 | 0.576 |
| 5 | Gilteritinib | 76.8% | 23.2% | 88.97 | 0.506 |
| 6 | Brigatinib | 75.6% | 24.4% | 82.96 | 0.513 |
| 7 | Abemaciclib | 74.4% | 25.6% | 91.48 | 0.563 |
| 8 | Fostamatinib | 72.5% | 27.5% | 96.74 | 0.613 |
| 9 | Pacritinib | 69.9% | 30.1% | 88.64 | 0.452 |
| 10 | Pazopanib | 60.4% | 39.6% | 97.49 | 0.672 |
| 11 | Nilotinib | 49.7% | 50.3% | 96.49 | 0.765 |
| 12 | Palbociclib | 47.4% | 52.6% | 98.75 | 0.673 |
| 13 | Dabrafenib | 39.7% | 60.3% | 94.74 | 0.633 |
| 14 | Defactinib | 38.5% | 61.5% | 92.68 | 0.450 |
| 15 | Canertinib | 34.8% | 65.2% | 96.49 | 0.671 |
| 16 | Vemurafenib | 33.3% | 66.7% | 96.49 | 0.598 |
| 17 | Ponatinib | 29.2% | 70.8% | 78.23 | 0.534 |
| 18 | Apatinib | 28.8% | 71.2% | 97.73 | 0.704 |
| 19 | Ceritinib | 28.2% | 71.8% | 95.44 | 0.618 |
| 20 | Umbralisib | 25.4% | 74.6% | 98.74 | 0.670 |
Paralog block
No paralog group registered for this kinase.
EMT expression
- Mesenchymal log2(TPM+1): 1.22
- Epithelial log2(TPM+1): 1.29
- Fold change: -0.08
- Status: No significant change
Selectivity landscape vs inhibition on MAPK10
Each point is one of the 92 approved drugs; color = inhibition % on MAPK10.
3D structure
Embedded NGL viewer pulls a representative PDB entry (or AlphaFold model if no experimental structure is registered). Heavy bundle — loaded only on demand.
Annotations
Sign in to read and post annotations.
Loading…